{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T17:59:16Z","timestamp":1793469556960,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T00:00:00Z","timestamp":1657584000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.semarthrit.2022.152069","type":"journal-article","created":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T02:02:15Z","timestamp":1657677735000},"page":"152069","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"C","title":["Concurrent baseline diagnosis of giant cell arteritis and polymyalgia rheumatica \u2013 A systematic review and meta-analysis"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8180-6871","authenticated-orcid":false,"given":"Andreas Wiggers","family":"Nielsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Line Lier","family":"Fr\u00f8lund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoffer","family":"V\u00e5ben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asta Roos","family":"Bonde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars Christian","family":"Gormsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette Ladefoged","family":"de Thurah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen-Margrethe","family":"Hauge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kresten Krarup","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.semarthrit.2022.152069_bib0001","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.4065\/81.8.1071","article-title":"The early history of giant cell arteritis and polymyalgia rheumatica: first descriptions to 1970","volume":"81","author":"Hunder","year":"2006","journal-title":"Mayo Clin Proc"},{"issue":"10103","key":"10.1016\/j.semarthrit.2022.152069_bib0002","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/S0140-6736(17)31825-1","article-title":"Polymyalgia rheumatica","volume":"390","author":"Gonz\u00e1lez-Gay","year":"2017","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.semarthrit.2022.152069_bib0003","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/art.1780380311","article-title":"Epidemiology of polymyalgia rheumatica in Olmsted County, Minnesota, 1970-1991","volume":"38","author":"Salvarani","year":"1995","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.semarthrit.2022.152069_bib0004","first-page":"2166","article-title":"Giant cell arteritis in Lugo, Spain: A more frequent disease with fewer classic features","volume":"24","author":"Gonz\u00e1lez-Gay","year":"1997","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2022.152069_bib0005","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11926-014-0480-1","article-title":"Giant cell arteritis and polymyalgia rheumatica: an update","volume":"17","author":"Gonz\u00e1lez-Gay","year":"2015","journal-title":"Curr Rheumatol Rep"},{"issue":"9634","key":"10.1016\/j.semarthrit.2022.152069_bib0006","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0140-6736(08)61077-6","article-title":"Polymyalgia rheumatica and giant-cell arteritis","volume":"372","author":"Salvarani","year":"2008","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152069_bib0007","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s00259-018-4106-0","article-title":"Simple dichotomous assessment of cranial artery inflammation by conventional 18F-FDG PET\/CT shows high accuracy for the diagnosis of giant cell arteritis: a case-control study","volume":"46","author":"Nielsen","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"10.1016\/j.semarthrit.2022.152069_bib0008","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/art.1780330810","article-title":"The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis","volume":"33","author":"Hunder","year":"1990","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.semarthrit.2022.152069_bib0009","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1002\/art.21226","article-title":"Assessment of the cranial involvement pattern of giant cell arteritis with 3T magnetic resonance imaging","volume":"52","author":"Bley","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.semarthrit.2022.152069_bib0010","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/rheumatology\/keu329","article-title":"Large-vessel giant cell arteritis: a cohort study","volume":"54","author":"Muratore","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"10.1016\/j.semarthrit.2022.152069_bib0011","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1093\/rheumatology\/kez568","article-title":"Diagnostic accuracy of ultrasound for detecting large-vessel giant cell arteritis using FDG PET\/CT as the reference","volume":"59","author":"Nielsen","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.semarthrit.2022.152069_bib0012","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.autrev.2017.11.029","article-title":"Large-vessel involvement and aortic dilation in giant-cell arteritis. A multicenter study of 549 patients","volume":"17","author":"de Boysson","year":"2018","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.semarthrit.2022.152069_bib0013","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1136\/annrheumdis-2017-212649","article-title":"EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice","volume":"77","author":"Dejaco","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2022.152069_bib0014","doi-asserted-by":"crossref","first-page":"ii22","DOI":"10.1093\/rheumatology\/kex461","article-title":"Ultrasound in the diagnosis and management of giant cell arteritis","volume":"57","author":"Schmidt","year":"2018","journal-title":"Rheumatology (United Kingdom)"},{"key":"10.1016\/j.semarthrit.2022.152069_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2021.105185","article-title":"Fast track clinic for early diagnosis of polymyalgia rheumatica: Impact on symptom duration and prednisolone initiation","volume":"88","author":"Fr\u00f8lund","year":"2021","journal-title":"Joint Bone Spine"},{"issue":"8","key":"10.1016\/j.semarthrit.2022.152069_bib0016","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/art.40864","article-title":"Diagnostic Accuracy of Positron Emission Tomography\/Computed Tomography of the Head, Neck, and Chest for Giant Cell Arteritis: A Prospective, Double-Blind, Cross-Sectional Study","volume":"71","author":"Sammel","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2022.152069_bib0017","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/art.34356","article-title":"2012 Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative","volume":"64","author":"Dasgupta","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152069_bib0018","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4081\/reumatismo.2018.1107","article-title":"Contribution of the new 2012 EULAR\/ACR classification criteria for the diagnosis of polymyalgia rheumatica","volume":"70","author":"Muratore","year":"2018","journal-title":"Reumatismo"},{"issue":"5","key":"10.1016\/j.semarthrit.2022.152069_bib0019","doi-asserted-by":"crossref","first-page":"893","DOI":"10.3899\/jrheum.151103","article-title":"Assessment of the New 2012 EULAR\/ACR Clinical Classification Criteria for Polymyalgia Rheumatica: A Prospective Multicenter Study","volume":"43","author":"Ozen","year":"2016","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2022.152069_bib0020","doi-asserted-by":"crossref","first-page":"672","DOI":"10.7326\/0003-4819-97-5-672","article-title":"Polymyalgia rheumatica. A 10-year epidemiologic and clinical study","volume":"97","author":"Chuang","year":"1982","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.semarthrit.2022.152069_bib0021","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1136\/ard.38.5.434","article-title":"An evaluation of criteria for polymyalgia rheumatica","volume":"38","author":"Bird","year":"1979","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.semarthrit.2022.152069_bib0022","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/0049-0172(84)90012-X","article-title":"Long-term follow-up of polymyalgia rheumatica: evidence for synovitis","volume":"13","author":"Healey","year":"1984","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.semarthrit.2022.152069_bib0023","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/art.20231","article-title":"Giant cell arteritis without clinically evident vascular involvement in a defined population","volume":"51","author":"Gonzalez-Gay","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152069_bib0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"issue":"12","key":"10.1016\/j.semarthrit.2022.152069_bib0025","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-011458","article-title":"Development of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS)","volume":"6","author":"Downes","year":"2016","journal-title":"BMJ Open"},{"issue":"7414","key":"10.1016\/j.semarthrit.2022.152069_bib0026","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.semarthrit.2022.152069_bib0027","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/1529-0131(199906)42:6<1259::AID-ANR24>3.0.CO;2-I","article-title":"Musculoskeletal manifestations in a population-based cohort of patients with giant cell arteritis","volume":"42","author":"Salvarani","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2022.152069_bib0028","doi-asserted-by":"crossref","DOI":"10.1111\/joim.13446","article-title":"Risk of venous and arterial thromboembolism in patients with giant cell arteritis and\/or polymyalgia rheumatica: A Veterans Health Administration population-based study in the United States","author":"Michailidou","year":"2022","journal-title":"J Intern Med"},{"issue":"3","key":"10.1016\/j.semarthrit.2022.152069_bib0029","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/j.1756-185X.2010.01527.x","article-title":"Lack of association of high body mass index with risk for developing polymyalgia rheumatica","volume":"13","author":"Hoganson","year":"2010","journal-title":"International Journal of Rheumatic Diseases"},{"issue":"6","key":"10.1016\/j.semarthrit.2022.152069_bib0030","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1080\/03009742.2016.1266030","article-title":"Risk of ocular manifestations in patients with giant cell arteritis: a nationwide study in Sweden","volume":"46","author":"Ji","year":"2017","journal-title":"Scand J Rheumatol"},{"issue":"36","key":"10.1016\/j.semarthrit.2022.152069_bib0031","doi-asserted-by":"crossref","first-page":"e241","DOI":"10.3346\/jkms.2018.33.e241","article-title":"Characteristics of Korean Patients with Polymyalgia Rheumatica: a Single Locomotive Pain Clinic Cohort Study","volume":"33","author":"Do","year":"2018","journal-title":"J Korean Med Sci"},{"issue":"2","key":"10.1016\/j.semarthrit.2022.152069_bib0032","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s11845-018-1903-1","article-title":"Differences in clinical manifestations and prognosis of Chinese giant cell arteritis patients with or without polymyalgia rheumatica","volume":"188","author":"Zhang","year":"2019","journal-title":"Ir J Med Sci"},{"issue":"4","key":"10.1016\/j.semarthrit.2022.152069_bib0033","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/01.rhu.0000231381.21179.e6","article-title":"Peripheral musculoskeletal manifestations in polymyalgia rheumatica","volume":"12","author":"Ceccato","year":"2006","journal-title":"Journal of Clinical Rheumatology"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152069_bib0034","first-page":"99","article-title":"Clinical outcome of 149 patients with polymyalgia rheumatica and giant cell arteritis","volume":"25","author":"Bahlas","year":"1998","journal-title":"J Rheumatol"},{"issue":"8","key":"10.1016\/j.semarthrit.2022.152069_bib0035","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1002\/art.23700","article-title":"Small-vessel vasculitis surrounding an uninflamed temporal artery: A new diagnostic criterion for polymyalgia rheumatica?","volume":"58","author":"Chatelain","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.semarthrit.2022.152069_bib0036","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/rheumatology\/kep395","article-title":"Can the prognosis of polymyalgia rheumatica be predicted at disease onset? Results from a 5-year prospective study","volume":"49","author":"Mackie","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152069_bib0037","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/ard.40.1.1","article-title":"Prognosis and management of polymyalgia rheumatica","volume":"40","author":"Jones","year":"1981","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.semarthrit.2022.152069_bib0038","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0002-9343(85)90309-2","article-title":"Polymyalgia rheumatica. Duration of therapy and long-term outcome","volume":"79","author":"Ayoub","year":"1985","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.semarthrit.2022.152069_bib0039","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/art.1780340313","article-title":"Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in northern Italy","volume":"34","author":"Salvarani","year":"1991","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.semarthrit.2022.152069_bib0040","first-page":"1694","article-title":"A longitudinal study of anticardiolipin antibody in polymyalgia rheumatica and giant cell arteritis","volume":"22","author":"Chakravarty","year":"1995","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152069_bib0041","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/rheumatology\/41.1.46","article-title":"Incidence of temporal arteritis in patients with polymyalgia rheumatica: A prospective study using colour Doppler ultrasonography of the temporal arteries","volume":"41","author":"Schmidt","year":"2002","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152069_bib0042","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1297-319X(02)00007-6","article-title":"Temporal arteritis and polymyalgia rheumatica in north-eastern Spain: Clinical spectrum and relationship over a 15 year period","volume":"70","author":"Narv\u00e1ez","year":"2003","journal-title":"Joint Bone Spine"},{"issue":"12","key":"10.1016\/j.semarthrit.2022.152069_bib0043","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/ard.52.12.847","article-title":"The clinical and laboratory course of polymyalgia rheumatica\/giant cell arteritis after the first two months of treatment","volume":"52","author":"Kyle","year":"1993","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152069_bib0044","doi-asserted-by":"crossref","first-page":"6220","DOI":"10.1038\/s41598-021-85857-4","article-title":"Prognostic impacts of glucocorticoid treatment in patients with polymyalgia rheumatica and giant cell arteritis","volume":"11","author":"Emamifar","year":"2021","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.semarthrit.2022.152069_bib0045","first-page":"1340","article-title":"Restricted dose and duration of corticosteroid treatment in patients with polymyalgia rheumatica and temporal arteritis","volume":"17","author":"Lundberg","year":"1990","journal-title":"J Rheumatol"},{"issue":"9","key":"10.1016\/j.semarthrit.2022.152069_bib0046","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1136\/ard.47.9.733","article-title":"Polymyalgia rheumatica and temporal arteritis: A retrospective analysis of prognostic features and different corticosteroid regimens (11 year survey of 210 patients)","volume":"47","author":"Delecoeuillerie","year":"1988","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.semarthrit.2022.152069_bib0047","first-page":"1326","article-title":"The spectrum of polymyalgia rheumatica in northwestern Spain: incidence and analysis of variables associated with relapse in a 10 year study","volume":"26","author":"Gonz\u00e1lez-Gay","year":"1999","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152069_bib0048","first-page":"176","article-title":"High angiopoietin-2 levels associate with arterial inflammation and long-term glucocorticoid requirement in polymyalgia rheumatica","volume":"59","author":"van Sleen","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"10.1016\/j.semarthrit.2022.152069_bib0049","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1093\/rheumatology\/keaa058","article-title":"Risk factors for severe cranial ischaemic complications in giant cell arteritis","volume":"59","author":"Ho\u010devar","year":"2020","journal-title":"Rheumatology (United Kingdom)"},{"key":"10.1016\/j.semarthrit.2022.152069_bib0050","doi-asserted-by":"crossref","first-page":"775","DOI":"10.2147\/OPTH.S243203","article-title":"Giant cell arteritis: The experience of two collaborative referral centers and an overview of disease pathogenesis and therapeutic advancements","volume":"14","author":"Dammacco","year":"2020","journal-title":"Clinical Ophthalmology"},{"issue":"6","key":"10.1016\/j.semarthrit.2022.152069_bib0051","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/ggi.12536","article-title":"Giant cell arteritis (Horton's disease) in very elderly patients aged 80 years and older: A study of 25 cases","volume":"16","author":"Muller","year":"2016","journal-title":"Geriatrics and Gerontology International"},{"issue":"3 SUPPL. 49","key":"10.1016\/j.semarthrit.2022.152069_bib0052","first-page":"S16","article-title":"Implication of the age in the clinical spectrum of giant cell arteritis","volume":"26","author":"Lopez-Diaz","year":"2008","journal-title":"Clin Exp Rheumatol"},{"issue":"19","key":"10.1016\/j.semarthrit.2022.152069_bib0053","article-title":"Flares in biopsy-proven giant cell arteritis in northern Italy characteristics and predictors in a long-term follow-up study","volume":"95","author":"Restuccia","year":"2016","journal-title":"Medicine (United States)"},{"issue":"2","key":"10.1016\/j.semarthrit.2022.152069_bib0054","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.semarthrit.2019.02.011","article-title":"Features and prognosis of giant cell arteritis in patients over 85 years of age: A case-control study","volume":"49","author":"Liozon","year":"2019","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.semarthrit.2022.152069_bib0055","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.semarthrit.2020.04.004","article-title":"Relapses and long-term remission in large vessel giant cell arteritis in northern Italy: Characteristics and predictors in a long-term follow-up study","volume":"50","author":"Muratore","year":"2020","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152069_bib0056","first-page":"65","article-title":"Relapse in a population based cohort of patients with polymyalgia rheumatica","volume":"32","author":"Kremers","year":"2005","journal-title":"J Rheumatol"},{"issue":"22","key":"10.1016\/j.semarthrit.2022.152069_bib0057","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1001\/jama.2016.5444","article-title":"Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review","volume":"315","author":"Buttgereit","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.semarthrit.2022.152069_bib0058","doi-asserted-by":"crossref","DOI":"10.1111\/joim.13525","article-title":"An update on polymyalgia rheumatica","author":"Lundberg","year":"2022","journal-title":"J Intern Med"},{"issue":"9860","key":"10.1016\/j.semarthrit.2022.152069_bib0059","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0140-6736(12)60680-1","article-title":"Polymyalgia rheumatica","volume":"381","author":"Kermani","year":"2013","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152069_bib0060","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/rheumatology\/kev289","article-title":"The fast-track ultrasound clinic for early diagnosis of giant cell arteritis significantly reduces permanent visual impairment: towards a more effective strategy to improve clinical outcome in giant cell arteritis?","volume":"55","author":"Diamantopoulos","year":"2016","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"10.1016\/j.semarthrit.2022.152069_bib0061","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1097\/MNM.0000000000001292","article-title":"Diagnostic performance of F-18 fluorodeoxyglucose PET\/computed tomography for diagnosis of polymyalgia rheumatica: a meta-analysis","volume":"41","author":"Kim","year":"2020","journal-title":"Nucl Med Commun"},{"issue":"6","key":"10.1016\/j.semarthrit.2022.152069_bib0062","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1007\/s00259-020-05162-6","article-title":"Diagnostic value of [18F]FDG-PET\/CT in polymyalgia rheumatica: a systematic review and meta-analysis","volume":"48","author":"van der Geest","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"11","key":"10.1016\/j.semarthrit.2022.152069_bib0063","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/imj.12823","article-title":"Recent advances in polymyalgia rheumatica","volume":"45","author":"Owen","year":"2015","journal-title":"Intern Med J"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152069_bib0064","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12874-020-00975-3","article-title":"How are systematic reviews of prevalence conducted? A methodological study","volume":"20","author":"Borges Migliavaca","year":"2020","journal-title":"BMC Med Res Methodol"},{"issue":"10","key":"10.1016\/j.semarthrit.2022.152069_bib0065","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/nrrheum.2017.142","article-title":"Giant cell arteritis and polymyalgia rheumatica: current challenges and opportunities","volume":"13","author":"Dejaco","year":"2017","journal-title":"Nat Rev Rheumatol"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017222001202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017222001202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:10:41Z","timestamp":1758733841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017222001202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":65,"alternative-id":["S0049017222001202"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2022.152069","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Concurrent baseline diagnosis of giant cell arteritis and polymyalgia rheumatica \u2013 A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2022.152069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152069"}}